Literature DB >> 16534207

Orbitofrontal dysfunction related to both apathy and disinhibition in frontotemporal dementia.

Frédéric Peters1, Daniela Perani, Karl Herholz, Vjera Holthoff, Bettina Beuthien-Baumann, Sandro Sorbi, Alberto Pupi, Christian Degueldre, Christian Lemaire, Fabienne Collette, Eric Salmon.   

Abstract

Orbitofrontal metabolic impairment is characteristic of the frontal variant of frontotemporal dementia (fv-FTD), as are early changes in emotional and social conduct. Two main types of behavioral disturbances have been distinguished in fv-FTD patients: apathetic and disinhibited manifestations. In this study, we searched for relationships between brain metabolism and presence of apathetic or disinhibited behavior. Metabolic activity and behavioral data were collected in 41 fv-FTD patients from European PET centers. A conjunction analysis of the PET data showed an expected impairment of metabolic activity in the anterior cingulate, ventromedial and orbital prefrontal cortex, the dorsolateral prefrontal cortex and the left anterior insula in fv-FTD subjects compared to matched controls. A correlation was observed between disinhibition scores on the Neuropsychiatric Inventory scale and a cluster of voxels located in the posterior orbitofrontal cortex (6, 28, -24). Comparison of brain activity between apathetic and nonapathetic fv-FTD patients from two centers also revealed a specific involvement of the posterior orbitofrontal cortex in apathetic subjects (4, 22, -22). The results confirm that the main cerebral metabolic impairment in fv-FTD patients affects areas specializing in emotional evaluation and demonstrate that decreased orbitofrontal activity is related to both disinhibited and apathetic syndromes in fv-FTD. Copyright (c) 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16534207     DOI: 10.1159/000091898

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  57 in total

1.  Relationship between dose, drug levels, and D2 receptor occupancy for the atypical antipsychotics risperidone and paliperidone.

Authors:  E C Muly; J R Votaw; J Ritchie; L L Howell
Journal:  J Pharmacol Exp Ther       Date:  2012-01-03       Impact factor: 4.030

2.  Emotion regulation deficits in frontotemporal lobar degeneration and Alzheimer's disease.

Authors:  Madeleine S Goodkind; Anett Gyurak; Megan McCarthy; Bruce L Miller; Robert W Levenson
Journal:  Psychol Aging       Date:  2010-03

3.  Neuroanatomical correlates of emotional blunting in behavioral variant frontotemporal dementia and early-onset Alzheimer's disease.

Authors:  Grace J Lee; Po H Lu; Michelle J Mather; Jill Shapira; Elvira Jimenez; Alex D Leow; Paul M Thompson; Mario F Mendez
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

4.  Neuropsychiatric symptoms in primary progressive aphasia: phenomenology, pathophysiology, and approach to assessment and treatment.

Authors:  Mandana Modirrousta; Bruce H Price; Bradford C Dickerson
Journal:  Neurodegener Dis Manag       Date:  2013-04-01

Review 5.  Apathy in neuropsychiatric disease: diagnosis, pathophysiology, and treatment.

Authors:  Thomas N Chase
Journal:  Neurotox Res       Date:  2010-05-15       Impact factor: 3.911

6.  Apathy and disinhibition in frontotemporal dementia: Insights into their neural correlates.

Authors:  G Zamboni; E D Huey; F Krueger; P F Nichelli; J Grafman
Journal:  Neurology       Date:  2008-09-02       Impact factor: 9.910

7.  The neuropsychological correlates of pathological lying: evidence from behavioral variant frontotemporal dementia.

Authors:  Michele Poletti; Paolo Borelli; Ubaldo Bonuccelli
Journal:  J Neurol       Date:  2011-04-22       Impact factor: 4.849

Review 8.  Emotional and behavioral symptoms in neurodegenerative disease: a model for studying the neural bases of psychopathology.

Authors:  Robert W Levenson; Virginia E Sturm; Claudia M Haase
Journal:  Annu Rev Clin Psychol       Date:  2014-01-15       Impact factor: 18.561

9.  The tauopathy associated with mutation +3 in intron 10 of Tau: characterization of the MSTD family.

Authors:  Salvatore Spina; Martin R Farlow; Frederick W Unverzagt; David A Kareken; Jill R Murrell; Graham Fraser; Francine Epperson; R Anthony Crowther; Maria G Spillantini; Michel Goedert; Bernardino Ghetti
Journal:  Brain       Date:  2007-12-07       Impact factor: 13.501

10.  Phenomenology and anatomy of abnormal behaviours in primary progressive aphasia.

Authors:  Jonathan D Rohrer; Jason D Warren
Journal:  J Neurol Sci       Date:  2010-04-18       Impact factor: 3.181

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.